These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1680990)

  • 1. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
    Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
    J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
    Shibayama T; Nakazono M; Koyama Y; Deguchi N; Baba S; Jitsukawa S; Murai M; Tazaki H
    Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Utility of the serum CRP value for assessing the prognosis and therapeutic response of urological malignancies].
    Köhler A; Eggers H; Kuczyk MA; Schrader AJ; Steffens S
    Aktuelle Urol; 2013 Nov; 44(6):452-5. PubMed ID: 24258396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
    Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
    Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
    Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S
    Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on serum levels of immunosuppressive acidic protein (IAP) as a marker of renal cell carcinoma].
    Hoshino M; Fuji K; Kataoka K; Inoue K; Higaki Y; Imamura K
    Hinyokika Kiyo; 1989 Oct; 35(10):1647-52. PubMed ID: 2610170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer.
    Alevizopoulos A; Tyritzis S; Leotsakos I; Anastasopoulou I; Pournaras C; Kotsis P; Katsarou O; Alamanis C; Stravodimos K; Constantinides C
    Int J Urol; 2017 Feb; 24(2):130-136. PubMed ID: 28004432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
    Jou YC; Tsai YS; Hsieh HY; Chen SY; Tsai HT; Chen KJ; Wang ST; Shiau AL; Wu CL; Tzai TS
    Urol Oncol; 2013 Nov; 31(8):1806-11. PubMed ID: 22609059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum immunosuppressive acid protein predicts lymph node metastases in patients with renal cell carcinoma.
    Pummer K; Pürstner P; Auner HL; Stettner H; Trummer H; Penkoff H; Rauchenwald M
    Br J Urol; 1994 Jun; 73(6):612-4. PubMed ID: 8032825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in serum immunosuppressive acidic protein following surgery in patients with renal carcinoma.
    Ueda T; Yasumasu T; Uozumi J; Naito S
    Br J Urol; 1993 Oct; 72(4):409-12. PubMed ID: 8261296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
    Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
    Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammatory reaction and laboratory tests: IAP (immunosuppressive acidic protein)].
    Sato T; Sakata Y; Tamura K
    Rinsho Byori; 1990 Mar; 38(3):255-9. PubMed ID: 2190023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies of the cellular immune response in patients with urinary bladder carcinoma. X. Evaluation of serum IAP and ASP levels].
    Nishio S; Ozaki Y; Wada S; Kawakita J; Maekawa M
    Hinyokika Kiyo; 1984 Apr; 30(4):449-57. PubMed ID: 6485956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
    Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
    Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of serum immunosuppressive acidic protein for staging renal cell carcinoma: comparison with other tumour markers.
    Masuda H; Kurita Y; Suzuki K; Fujita K; Aso Y
    Br J Urol; 1997 Jul; 80(1):25-9. PubMed ID: 9240175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin used as prognostic marker of urological tumors.
    Jungwirth N; Haeberle L; Schrott KM; Wullich B; Krause FS
    World J Urol; 2008 Oct; 26(5):499-504. PubMed ID: 18581119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of Reg IV in urogenital organs: Frequent expression of Reg IV in prostate cancer and potential utility as serum tumor marker.
    Hayashi T; Matsubara A; Ohara S; Mita K; Hasegawa Y; Usui T; Arihiro K; Norimura S; Sentani K; Oue N; Yasui W
    Oncol Rep; 2009 Jan; 21(1):95-100. PubMed ID: 19082448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of C-reactive protein in urological cancers: a useful biomarker for predicting outcomes.
    Saito K; Kihara K
    Int J Urol; 2013 Feb; 20(2):161-71. PubMed ID: 22897628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma.
    Sasagawa I; Nakada T; Kubota Y; Suzuki H; Sawamura T
    Br J Urol; 1994 Apr; 73(4):355-7. PubMed ID: 8199820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.
    Traeger L; Ellermann I; Wiethoff H; Ihbe J; Gallitz I; Eveslage M; Moritz R; Herrmann E; Schrader AJ; Steinbicker AU
    BMC Cancer; 2019 Jan; 19(1):74. PubMed ID: 30646851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.